Clinical Trial Update: Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating umbilical cord-derived mesenchymal stem cells for ischemic stroke has completed. Sponsor: General Hospital of Shenyang …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED